Delayed recurrence of atrial fibrillation 2 years after catheter ablation is associated with metabolic syndrome

Yong Soo Baek, Pil Sung Yang, Tae Hoon Kim, Jae Sun Uhm, Jong Youn Kim, Boyoung Joung, Moon Hyoung Lee, huinam pak

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Whether delayed clinical recurrence of atrial fibrillation (AF) 2 years after radiofrequency catheter ablation (CR> 2-years) is related to AF progression remains unclear. Objective We hypothesized that metabolic factors are associated with CL> 2-years. Methods Among 1825 patients who underwent catheter ablation, the study included 523 patients with AF recurrence (27.2% women, mean age 57 ± 11 years, 58.3% paroxysmal AF) 3 months after the ablation procedure. They were divided into the clinical recurrence within 2-years (CL≤ 2-years: AF recurrence at 3–24 months) and CL> 2-years (AF recurrence > 24 months) groups. Clinical and imaging parameters and polysomnograms were compared. Results Over 42 ± 19 months of follow-up, 409 (78.2%) and 114 (21.8%) patients formed the CL≤ 2-years and CL> 2-years groups, respectively. The CL> 2-years group had higher proportions of overweight (p = 0.004), hypertension (p = 0.049), diabetes mellitus (p = 0.037), dyslipidemia (p = 0.009), high sensitivity C-reactive protein > 8 mg/L (p = 0.049), and metabolic syndrome (p = 0.011) than the CL≤ 2-years group. Despite no significant difference between the apnea and hypopnea indices in the CL≤ 2-years (n = 97) and CL> 2-years (n = 28) groups, the minimum peripheral oxygen saturation was significantly lower in the latter than the former (p = 0.032). In the multivariate analysis, overweight (odds ratio [OR] 1.756, 95% confidence interval [CI] 1.146–2.693, p = 0.010), dyslipidemia (OR 1.587, 95% CI 1.033–2.438, p = 0.035), and metabolic syndrome (OR 1.972, 95% CI 1.158–3.356, p = 0.012) were independently associated with CL> 2-years. Conclusions Overweight, dyslipidemia, and metabolic syndrome are independent predictors of CL> 2-years for AF after catheter ablation. CL> 2-years seems to be affected by metabolic factors and can be related to AF progression.

Original languageEnglish
Pages (from-to)276-281
Number of pages6
JournalInternational Journal of Cardiology
Volume223
DOIs
Publication statusPublished - 2016 Nov 15

Fingerprint

Catheter Ablation
Atrial Fibrillation
Recurrence
Dyslipidemias
Odds Ratio
Confidence Intervals
Apnea
C-Reactive Protein
Diabetes Mellitus
Multivariate Analysis
Oxygen
Hypertension

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Baek, Yong Soo ; Yang, Pil Sung ; Kim, Tae Hoon ; Uhm, Jae Sun ; Kim, Jong Youn ; Joung, Boyoung ; Lee, Moon Hyoung ; pak, huinam. / Delayed recurrence of atrial fibrillation 2 years after catheter ablation is associated with metabolic syndrome. In: International Journal of Cardiology. 2016 ; Vol. 223. pp. 276-281.
@article{983efd3518a24e168cded414d7a7c4aa,
title = "Delayed recurrence of atrial fibrillation 2 years after catheter ablation is associated with metabolic syndrome",
abstract = "Background Whether delayed clinical recurrence of atrial fibrillation (AF) 2 years after radiofrequency catheter ablation (CR> 2-years) is related to AF progression remains unclear. Objective We hypothesized that metabolic factors are associated with CL> 2-years. Methods Among 1825 patients who underwent catheter ablation, the study included 523 patients with AF recurrence (27.2{\%} women, mean age 57 ± 11 years, 58.3{\%} paroxysmal AF) 3 months after the ablation procedure. They were divided into the clinical recurrence within 2-years (CL≤ 2-years: AF recurrence at 3–24 months) and CL> 2-years (AF recurrence > 24 months) groups. Clinical and imaging parameters and polysomnograms were compared. Results Over 42 ± 19 months of follow-up, 409 (78.2{\%}) and 114 (21.8{\%}) patients formed the CL≤ 2-years and CL> 2-years groups, respectively. The CL> 2-years group had higher proportions of overweight (p = 0.004), hypertension (p = 0.049), diabetes mellitus (p = 0.037), dyslipidemia (p = 0.009), high sensitivity C-reactive protein > 8 mg/L (p = 0.049), and metabolic syndrome (p = 0.011) than the CL≤ 2-years group. Despite no significant difference between the apnea and hypopnea indices in the CL≤ 2-years (n = 97) and CL> 2-years (n = 28) groups, the minimum peripheral oxygen saturation was significantly lower in the latter than the former (p = 0.032). In the multivariate analysis, overweight (odds ratio [OR] 1.756, 95{\%} confidence interval [CI] 1.146–2.693, p = 0.010), dyslipidemia (OR 1.587, 95{\%} CI 1.033–2.438, p = 0.035), and metabolic syndrome (OR 1.972, 95{\%} CI 1.158–3.356, p = 0.012) were independently associated with CL> 2-years. Conclusions Overweight, dyslipidemia, and metabolic syndrome are independent predictors of CL> 2-years for AF after catheter ablation. CL> 2-years seems to be affected by metabolic factors and can be related to AF progression.",
author = "Baek, {Yong Soo} and Yang, {Pil Sung} and Kim, {Tae Hoon} and Uhm, {Jae Sun} and Kim, {Jong Youn} and Boyoung Joung and Lee, {Moon Hyoung} and huinam pak",
year = "2016",
month = "11",
day = "15",
doi = "10.1016/j.ijcard.2016.08.222",
language = "English",
volume = "223",
pages = "276--281",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

Delayed recurrence of atrial fibrillation 2 years after catheter ablation is associated with metabolic syndrome. / Baek, Yong Soo; Yang, Pil Sung; Kim, Tae Hoon; Uhm, Jae Sun; Kim, Jong Youn; Joung, Boyoung; Lee, Moon Hyoung; pak, huinam.

In: International Journal of Cardiology, Vol. 223, 15.11.2016, p. 276-281.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Delayed recurrence of atrial fibrillation 2 years after catheter ablation is associated with metabolic syndrome

AU - Baek, Yong Soo

AU - Yang, Pil Sung

AU - Kim, Tae Hoon

AU - Uhm, Jae Sun

AU - Kim, Jong Youn

AU - Joung, Boyoung

AU - Lee, Moon Hyoung

AU - pak, huinam

PY - 2016/11/15

Y1 - 2016/11/15

N2 - Background Whether delayed clinical recurrence of atrial fibrillation (AF) 2 years after radiofrequency catheter ablation (CR> 2-years) is related to AF progression remains unclear. Objective We hypothesized that metabolic factors are associated with CL> 2-years. Methods Among 1825 patients who underwent catheter ablation, the study included 523 patients with AF recurrence (27.2% women, mean age 57 ± 11 years, 58.3% paroxysmal AF) 3 months after the ablation procedure. They were divided into the clinical recurrence within 2-years (CL≤ 2-years: AF recurrence at 3–24 months) and CL> 2-years (AF recurrence > 24 months) groups. Clinical and imaging parameters and polysomnograms were compared. Results Over 42 ± 19 months of follow-up, 409 (78.2%) and 114 (21.8%) patients formed the CL≤ 2-years and CL> 2-years groups, respectively. The CL> 2-years group had higher proportions of overweight (p = 0.004), hypertension (p = 0.049), diabetes mellitus (p = 0.037), dyslipidemia (p = 0.009), high sensitivity C-reactive protein > 8 mg/L (p = 0.049), and metabolic syndrome (p = 0.011) than the CL≤ 2-years group. Despite no significant difference between the apnea and hypopnea indices in the CL≤ 2-years (n = 97) and CL> 2-years (n = 28) groups, the minimum peripheral oxygen saturation was significantly lower in the latter than the former (p = 0.032). In the multivariate analysis, overweight (odds ratio [OR] 1.756, 95% confidence interval [CI] 1.146–2.693, p = 0.010), dyslipidemia (OR 1.587, 95% CI 1.033–2.438, p = 0.035), and metabolic syndrome (OR 1.972, 95% CI 1.158–3.356, p = 0.012) were independently associated with CL> 2-years. Conclusions Overweight, dyslipidemia, and metabolic syndrome are independent predictors of CL> 2-years for AF after catheter ablation. CL> 2-years seems to be affected by metabolic factors and can be related to AF progression.

AB - Background Whether delayed clinical recurrence of atrial fibrillation (AF) 2 years after radiofrequency catheter ablation (CR> 2-years) is related to AF progression remains unclear. Objective We hypothesized that metabolic factors are associated with CL> 2-years. Methods Among 1825 patients who underwent catheter ablation, the study included 523 patients with AF recurrence (27.2% women, mean age 57 ± 11 years, 58.3% paroxysmal AF) 3 months after the ablation procedure. They were divided into the clinical recurrence within 2-years (CL≤ 2-years: AF recurrence at 3–24 months) and CL> 2-years (AF recurrence > 24 months) groups. Clinical and imaging parameters and polysomnograms were compared. Results Over 42 ± 19 months of follow-up, 409 (78.2%) and 114 (21.8%) patients formed the CL≤ 2-years and CL> 2-years groups, respectively. The CL> 2-years group had higher proportions of overweight (p = 0.004), hypertension (p = 0.049), diabetes mellitus (p = 0.037), dyslipidemia (p = 0.009), high sensitivity C-reactive protein > 8 mg/L (p = 0.049), and metabolic syndrome (p = 0.011) than the CL≤ 2-years group. Despite no significant difference between the apnea and hypopnea indices in the CL≤ 2-years (n = 97) and CL> 2-years (n = 28) groups, the minimum peripheral oxygen saturation was significantly lower in the latter than the former (p = 0.032). In the multivariate analysis, overweight (odds ratio [OR] 1.756, 95% confidence interval [CI] 1.146–2.693, p = 0.010), dyslipidemia (OR 1.587, 95% CI 1.033–2.438, p = 0.035), and metabolic syndrome (OR 1.972, 95% CI 1.158–3.356, p = 0.012) were independently associated with CL> 2-years. Conclusions Overweight, dyslipidemia, and metabolic syndrome are independent predictors of CL> 2-years for AF after catheter ablation. CL> 2-years seems to be affected by metabolic factors and can be related to AF progression.

UR - http://www.scopus.com/inward/record.url?scp=84982097950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982097950&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.08.222

DO - 10.1016/j.ijcard.2016.08.222

M3 - Article

VL - 223

SP - 276

EP - 281

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -